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1. Introduction
Obscure gastrointestinal bleeding (OGBI) has been defined as persistent or recurrent bleeding
from the gastrointestinal tract, even though initial gastrointestinal- and colon-endoscopy or
small bowel radiological imaging were performed for initial evaluation [1].
In 10-20% of cases of patients who present with gastrointestinal bleeding, the underlying
etiology may not be evident on initial evaluation. About half of these patients were observed
in recurrent or persistent bleeding and had to need the further challenge to both diagno‐
sis  and  management.  The  underlying  etiology  often  remains  difficult  to  define,  despite
extensive examinations.  This  fact  results  in  recurrent  hospitalization and multiple  blood
transfusions [2, 3].
Hemosuccus Pancreaticus is known to be a cause of OGIB. Lower and Farrel first reported that
blood was expelled into the duodenum via the main pancreatic duct [4]. The term ‘hemosuccus
pancreaticus’ was coined by Sandblom in 1970 [5]. Hemoductal pancreaticus was proposed
by Longmire and Rose in 1973 [6]. These terms describe the emission of red blood cells along
pancreatic ducts through the papilla.
Diagnosis of hemosuccus pancreaticus is often difficult because the condition involves
intermittent gastrointestinal bleeding. In this paper, we describe two rare cases of hemosuccus
pancreaticus from our clinical experience and discuss the diagnosis and pathogenesis of this
disease with a review of the literature.
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2. Case reports
2.1. Case report 1
A 47-year-old Japanese male had a past history of peritoneal drainage for acute necrotizing
pancreatitis at 23 years of age and a lateral pancreaticojejunostomy (Puestow procedure) for
chronic pancreatitis at age 31. The patient experienced several episodes of tarry stools follow‐
ing the Puestow operation. Physical examination on admission revealed severe conjunctiva
pallor and tarry stools.
Emergent gastrointestinal fiberscopy was performed, and no abnormal lesions were found in
the stomach or duodenum. Hemorrhagic scintigraphy and abdominal computed tomography
(CT) were also carried out, but no hemorrhagic lesions were found. After blood transfusion,
total colonoscopy was performed via insertion up to the terminal ileum, which also revealed
no abnormal lesions. Although interventional radiology was considered as a treatment option,
hemostasis seemed possible through conservative therapy alone. The bleeding point was
assumed to be in the upper jejunum, including the reconstructed jejunum.
Two week later, more tarry stools occurred, the patient went into hemodynamic shock and
subsequently underwent laparotomy without delay. After inspection of the whole abdomen,
the intestine was found to contain coagulated blood in the upper jejunum. Intra-operative
endoscopy through an incision in the reconstructed jejunal loop at the close proximal end
revealed massive bleeding. After suction of the bleeding and coagulation clots, an active
bleeding site from the side-to-side anastomotic pancreatic duct became clear (Fig. A). Longi‐
tudinal jejunotomy was performed, and the bleeding point was sutured and ligated [7].
Figure 1. Active bleeding from side-to-side pancreaticojejunostomy
2.2. Case report 2
A 45-year-old Japanese male had been treated by medication for chronic pancreatitis and
gastroduodenal peptic ulcer. The patient had a complaint of hematomesis and emergent
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gastrointestinal endoscopy revealed massive duodenal bleeding. Emergent distal gastrectomy
was performed. After discharge, he had epigastric pain and was re-admitted with a diagnosis
of chronic pancreatitis. Abdominal CT revealed splenomegaly and a pancreatic cyst in the
pancreatic tail. Angiography revealed aneurysm of the distal pancreatic artery. Distal pan‐
createctomy and splenectomy were performed. The resected specimen included was a
pseudocyst filled with a blood clot in the pancreatic tail, and it communicated with the main
pancreatic duct. Furthermore, the splenic artery had ruptured into the pseudocyst [8].
3. Diagnosis
3.1. Symptoms
The usual presentation of hemosuccus pancreaticus is the development of symptoms of upper
or lower gastrointestinal bleeding, such as hematomesis, vomiting of bloody contents, melena,
tarry stool, hematochezia, or fresh rectal bleeding. The feature of gastrointestinal bleeding is
that it is intermittent, waxing and waning. The bleeding source is not determined by standard
endoscopic technique as usual. The symptoms of this condition are categorized as a cause of
obscure overt gastrointestinal hemorrhage. Obscure gastrointestinal bleeding (OGBI) has been
defined as persistent or recurrent gastrointestinal bleeding, after negative initial examinations.
More than one half patients with hemosuccus pancreaticus also have symptoms as abdominal
pain, usually located in the epigastric lesion or upper part of the abdomen. The characteristics
of the pain is like being crescendo-decrescendo in nature, meaning that it slowly increases and
decreases in intensity with time. This symptom is thought to be due to transient blockage and
increasing pressure of the pancreatic duct from the source of bleeding or clots [9].
Table 1. Symptom of Hemosuccus Pancreaticus
3.2. OGIB: Obscure Gastrointestinal Bleeding
Obscure gastrointestinal bleeding (OGBI) has been defined as persistent or recurrent gastroin‐
testinal bleeding after negative initial evaluation by pan-endoscope and radiological small
intestinal imaging [9]. On initial endoscopic evaluation with standard endoscopy, such as
esophago-gastroduodenoscopy and colonoscopy, as well as the limited capacity of endos‐
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copy to examine the small bowel the main challenges related to the evaluation of OGBI include
the high miss rate for lesions. Therefore, the management of these patients has traditionally
required invasive procedures such as intra-operative enteroscopy and exploratory laparoto‐
my. The technological advances such as the introduction of video capsule endoscopy, single
and double balloon enteroscopy,  spiral  enteroscopy,  CT enterography can overcome the
limitation of old diagnostic modalities.
3.3. Diagnostic features
Hemosuccus pancreaticus is known to be a cause of OGIB. It is often difficult to diagnose
hemosuccus pancreaticus because the bleeding is usually intermittent. Endoscopy represents
the first diagnostic step in patients with upper gastrointestinal bleeding. Although it is
essential to rule out other causes of bleeding such as peptic ulcers, esophageal, and gastric
varices, endoscopy rarely identifies blood in the ampulla of Vater. Pancreatic pseudocysts or
aneurysms of peripancreatic arteries can be visualize by ultrasonography. Doppler ultrasound
and dynamic ultrasound have been also reported to be useful diagnostic modalities [10, 11].
And contrast-enhanced CT is an further excellent modality for demonstrating the feature of
chronic pancreatitis, pseudocysts and pseudoaneurysm [12, 13]. Selective angiography of the
celiac axis and the superior mesenteric artery provides formal proof of hemosuccus pancrea‐
ticus by opacifying the main pancreatic duct, the presence of an aneurysm or pseudo-aneurysm
with a high sensitivity [14].(Table 2) Diagnosis of hemosuccus pancreaticus accomplished by
advanced technologies such as video capsule endoscopy, single-and double-balloon entero‐
scopy, spiral enteroscopy, and computed tomography enterography has not been reported
until now. These advanced technologies provide vital information for the diagnosis of
hemosuccus pancreaticus.
Table 2. Diagnostic Modalities of Hemosuccus Pancreaticus
4. Pathogenesis and etiology
Hemosuccus pancreaticus complicates an underlying pancreatic disease in 80% of cases and
vascular anomaly in 20% of cases [15]. Chronic pancreatitis is the cause of about 90% of
pancreatic diseases [15, 16]. Several mechanisms are thought to be involved. A pseudocyst is
thought to be one of causes of hemosuccus pancreaticus, because of hemorrhagic pseudocyst
or communication of cyst to pericystic artery. Arterial aneurysm and pseudo-aneurysm are
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also known to be a cause of hemosuccus pancreaticus. These aneurysms are frequent in about
10 % in chronic pancreatitis. Vascular ulceration by pancreatic intraductal stone is also thought
to be a cause of hemosuccus pancreaticus [10, 18]. Although aneurysm and chronic pancreatitis
are often associated, there is no clear causal relationship. Other causes of hemosuccus pan‐
creaticus are rare: neuroendocrine tumor [15], intraductal papillary-mucinous carcinoma [19],
ectopic pancreas [20], pancreas divisum [21], and Puestow procedure [7]. Finally, hemosuccus
pancreaticus can result from a post ERCP (endoscopic retrograde cholangiopancreatography)
complication. As for acute pancreatitis, hemosuccus pancreaticus can occur after necrosis of
the adjacent arterial wall such as gastroduodenal artery, splenic artery, pancreaticoduodenal
arcade. The pathogenesis and etiology are summarized in Table 3.
Table 3. Pathogenesis and Etiology of Hemosuccus Pancreaticus
5. Management and treatment
The management for hemosuccus pancreaticus should be aimed at completely eradicating the
source of bleeding. Three therapeutic options are considered for this disorder: endoscopic
treatment, angiographic embolization, and surgery have been documented. Endoscopic
treatment was used in a rare case in which hemosuccus pancreaticus caused by post ERCP
pancreatitis was treated by endoscopic stent tree tamponade [22]. Interventional radiographic
methods are chosen for initial treatment when the hemodynamic situations is under control.
The treatment response rate was 67% to 100% of cases [23-25]. Most hemosuccus pancreaticus
cases can receive angiography. If the source of hemorrhage is found by angiography, inter‐
ventional radiological therapy should be done following this examination. Interventional
radiological therapy by implantation of an uncoated metal Palmaz stent across the aneurysmal
segment of splenic artery is also reported [26]. Transcatheter arterial embolization was
reported to be effective for hemosuccus pancreaticus treatment [27-29]. However, ischemia
also can develop in the tissue supplied by the artery if the collateral circulation is not sufficient,
and other complications of aneurysm infection and splenic infarction may arise. Sources
bleeding from a pseudoaneurysm were reported to arise from the splenic artery in most cases
but also the gastroduodenal artery, from the branch of the superior pancreaticoduodenal
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artery, from the branch of the inferior pancreaticoduodenal artery, from the superior mesen‐
teric artery or vein, and from an unnamed intracystic artery [30]. Some authors documented
that recurrent bleeding rates were about 30% [12]. Thus, arterial embolization is recommended
as the initial therapeutic method, either to stabilize the patient to perform elective surgery or
as a definitive treatment where possible [31, 32].
Surgical treatment is indicated in uncontrolled hemorrhage, persistent shock, where emboli‐
zation is not feasible or when embolization fails. Ligation of the pancreatic duct is one of the
surgical approaches, but results are unsatisfactory because the causal lesion remains intact.
Ligation of the causal artery is more effective but does not remove the risk of recurrence.
Pancreatic resection such as distal pancreatectomy, central pancreatectomy, or pancreatico‐
dudenectomy treats both the pancreatic and the arterial diseases. Distal pancreatectomy is
indicative for bleeding pseudoaneurysms in the body or tail of the pancreas. When the location
of the pseudoaneurysm is the head of the pancreas, pancreaticoduodenectomy is chosen.
However, increased mortality and morbidity have been reported, and consequently angioem‐
bolization alone has been proposed as the recommended treatment modality [25, 26, 31, 32].
Bleeding from the pancreaticoduodenal artery has a higher mortality rate than bleeding from
the splenic or gastroduodenal artery [31, 32]. Most patients suffer from chronic pancreatitis so
the potential perioperative complications and postoperative pancreatic insufficiency should
be noted. Most surgical series have documented success rates of 70% to 85% with mortality
rates of 20% to 25% and rebleeding rates of 0% to 5% [31-34]. The treatment options are
summarized in Table 4.
Table 4. Treatment of Hemosuccus Pancreaticus
6. Conclusion
A flow chart for management of hemosuccus pancreaticus is shown in Figure 1. Hemosuccus
pancreaticus is a rare and potentially life threatening clinical entity. It is the least frequent cause
of upper gastrointestinal bleeding and is most often caused by chronic pancreatitis. Its
diagnosis is difficult because of its rarity and its anatomical location as well as its intermitted
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bleeding. During the intermitted phase, it cannot be diagnosed by the upper gastrointestinal
endoscope. The timely diagnosis is often delayed because of the intermitted nature of bleeding.
Therapeutic options consist of embolization, stenting, endoscopic stenting, and surgery.
Endovascular therapy by embolization is effective in most patients, although to achieve a
complete cure there is no consensus on the need for surgery. Embolization can control unstable
haemodynamics. Emergent surgery is required in patients with recurrent bleeding or failed
first-line therapies such as embolization or stenting.
Figure 2. Flowchart for the management of hemosuccus pancreaticus
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